Fig. 3. Levels of tyrosine phosphorylation of epidermal growth factor receptor (EGFR) in the human corneal epithelial cell with or without lidocaine (4 μm –40 μM). The cells were incubated for 5 min with epidermal growth factor (EGF), lidocaine, or both. Equal amounts of human corneal epithelial cell protein were immunoprecipitated (IP) and immunoblotted (IB) with antiphosphotyrosine (pY) or anti-EGFR antibody. Solid bars  represent basal and EGF-stimulated levels of tyrosine phosphorylation as a percent of EGF-stimulated phosphorylation without lidocaine (100%). EGF-stimulated tyrosine phosphorylation of EGFR (IP: EGFR; IB: pY) was attenuated by lidocaine (expressed as percent phosphorylation normalized to EGFR protein level). EGFR protein content (IP: EGFR; IB: EGFR) was not altered by the addition of lidocaine. Results displayed in the upper panels  represent typical immunoblots of autophosphorylation of EGFR and immunoblots of protein content. *P < 0.05 and **P < 0.01 versus  EGF-stimulated tyrosine phosphorylation without lidocaine; n = 4 for each lane.

Fig. 3. Levels of tyrosine phosphorylation of epidermal growth factor receptor (EGFR) in the human corneal epithelial cell with or without lidocaine (4 μm –40 μM). The cells were incubated for 5 min with epidermal growth factor (EGF), lidocaine, or both. Equal amounts of human corneal epithelial cell protein were immunoprecipitated (IP) and immunoblotted (IB) with antiphosphotyrosine (pY) or anti-EGFR antibody. Solid bars  represent basal and EGF-stimulated levels of tyrosine phosphorylation as a percent of EGF-stimulated phosphorylation without lidocaine (100%). EGF-stimulated tyrosine phosphorylation of EGFR (IP: EGFR; IB: pY) was attenuated by lidocaine (expressed as percent phosphorylation normalized to EGFR protein level). EGFR protein content (IP: EGFR; IB: EGFR) was not altered by the addition of lidocaine. Results displayed in the upper panels  represent typical immunoblots of autophosphorylation of EGFR and immunoblots of protein content. *P < 0.05 and **P < 0.01 versus  EGF-stimulated tyrosine phosphorylation without lidocaine; n = 4 for each lane.

Close Modal

or Create an Account

Close Modal
Close Modal